Global Mebendazole Tablet Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Mebendazole Tablet Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Mebendazole Tablets are indicated for the treatment of pinworms, roundworms, whipworms, hookworms, strongyloides sterculoides and tapeworms alone or in combination.
Mebendazole Tablet report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mebendazole Tablet market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Threadworm Infection and Pinworm Infection are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Mebendazole Tablet industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Mebendazole Tablet key manufacturers include Johnson & Johnson, Wellona Pharma, Arpimed, AdvaCare, Anhui Medipharm, SPMC, NESTOR, LEXICARE PHARMA and NOUVASANT, etc. Johnson & Johnson, Wellona Pharma, Arpimed are top 3 players and held % sales share in total in 2022.
Mebendazole Tablet can be divided into 100mg and 500mg, etc. 100mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Mebendazole Tablet is widely used in various fields, such as Threadworm Infection, Pinworm Infection, Whipworm Infection and Others, etc. Threadworm Infection provides greatest supports to the Mebendazole Tablet industry development. In 2022, global % sales of Mebendazole Tablet went into Threadworm Infection filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mebendazole Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Johnson & Johnson
Wellona Pharma
Arpimed
AdvaCare
Anhui Medipharm
SPMC
NESTOR
LEXICARE PHARMA
NOUVASANT
Segment by Type
100mg
500mg
Threadworm Infection
Pinworm Infection
Whipworm Infection
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Mebendazole Tablet market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Mebendazole Tablet, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Mebendazole Tablet industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Mebendazole Tablet in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Mebendazole Tablet introduction, etc. Mebendazole Tablet Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Mebendazole Tablet market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Mebendazole Tablet report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mebendazole Tablet market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Threadworm Infection and Pinworm Infection are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Mebendazole Tablet industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Mebendazole Tablet key manufacturers include Johnson & Johnson, Wellona Pharma, Arpimed, AdvaCare, Anhui Medipharm, SPMC, NESTOR, LEXICARE PHARMA and NOUVASANT, etc. Johnson & Johnson, Wellona Pharma, Arpimed are top 3 players and held % sales share in total in 2022.
Mebendazole Tablet can be divided into 100mg and 500mg, etc. 100mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Mebendazole Tablet is widely used in various fields, such as Threadworm Infection, Pinworm Infection, Whipworm Infection and Others, etc. Threadworm Infection provides greatest supports to the Mebendazole Tablet industry development. In 2022, global % sales of Mebendazole Tablet went into Threadworm Infection filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mebendazole Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Johnson & Johnson
Wellona Pharma
Arpimed
AdvaCare
Anhui Medipharm
SPMC
NESTOR
LEXICARE PHARMA
NOUVASANT
Segment by Type
100mg
500mg
Segment by Application
Threadworm Infection
Pinworm Infection
Whipworm Infection
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Mebendazole Tablet market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Mebendazole Tablet, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Mebendazole Tablet industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Mebendazole Tablet in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Mebendazole Tablet introduction, etc. Mebendazole Tablet Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Mebendazole Tablet market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices